CN Stock MarketDetailed Quotes

002727 Yixintang Pharmaceutical

Watchlist
  • 20.75
  • -0.11-0.53%
Market Closed May 31 15:00 CST
12.37BMarket Cap22.41P/E (TTM)

Yixintang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
14.96%5.1B
-0.29%17.38B
6.55%12.81B
8.92%8.68B
11.02%4.44B
19.50%17.43B
14.55%12.03B
18.85%7.97B
16.53%4B
15.26%14.59B
Operating revenue
14.96%5.1B
-0.29%17.38B
6.55%12.81B
8.92%8.68B
11.02%4.44B
19.50%17.43B
14.55%12.03B
18.85%7.97B
16.53%4B
15.26%14.59B
Other operating revenue
----
63.86%503.73M
----
84.92%293.12M
----
-1.54%307.42M
----
-1.40%158.52M
----
22.43%312.21M
Total operating cost
15.97%4.78B
3.02%16.46B
6.81%11.96B
7.58%8.05B
8.63%4.12B
18.86%15.98B
16.48%11.2B
22.78%7.49B
20.95%3.8B
14.71%13.44B
Operating cost
20.44%3.55B
2.85%11.65B
10.03%8.57B
10.77%5.76B
11.42%2.95B
23.12%11.32B
19.89%7.79B
27.00%5.2B
22.54%2.65B
13.22%9.2B
Operating tax surcharges
-7.45%10.35M
118.49%78.93M
23.26%32.9M
35.04%22.47M
72.86%11.18M
-8.33%36.13M
-2.74%26.69M
-2.03%16.64M
-18.51%6.47M
22.42%39.41M
Operating expense
5.83%1.09B
4.00%4.23B
-0.69%3B
0.61%2.03B
2.90%1.03B
10.03%4.07B
9.51%3.02B
14.68%2.01B
18.86%1B
21.26%3.7B
Administration expense
-5.39%106.31M
-2.80%428.06M
8.30%320.84M
7.41%215.07M
-1.00%112.38M
10.35%440.38M
6.47%296.25M
8.37%200.23M
8.61%113.52M
-21.13%399.1M
Financial expense
9.00%18.53M
-36.19%62.22M
-45.45%38.87M
-58.72%20.3M
-32.79%17M
-3.32%97.51M
25.02%71.25M
30.94%49.17M
24.19%25.3M
2,326.50%100.86M
-Interest expense (Financial expense)
-2.60%35.7M
-8.01%135.34M
-9.54%94.62M
-13.92%58.94M
2.80%36.66M
8.00%147.12M
28.51%104.59M
32.81%68.48M
42.59%35.66M
455.08%136.22M
-Interest Income (Financial expense)
10.16%-18.29M
-45.26%-77.57M
-60.96%-58.93M
-92.78%-41.06M
-79.29%-20.35M
-36.06%-53.4M
-34.98%-36.61M
-36.15%-21.3M
-83.25%-11.35M
-62.41%-39.25M
Research and development
70.83%2.83M
16.70%10.2M
98.60%7.65M
166.53%4.49M
72.47%1.66M
62.23%8.74M
-0.38%3.85M
-55.63%1.69M
-49.88%962.08K
542.08%5.39M
Credit Impairment Loss
-28.66%-9.21M
49.20%-42.78M
26.02%-6.88M
-35.65%-4.87M
28.50%-7.16M
-1,729.09%-84.22M
-131.15%-9.3M
-41.80%-3.59M
-531.12%-10.01M
-73.98%-4.6M
Asset Impairment Loss
14.20%-31.51M
6.29%-164.94M
-3.62%-94.97M
-45.55%-65.33M
-138.01%-36.73M
-45.11%-176.01M
-25.66%-91.66M
7.21%-44.89M
29.30%-15.43M
-44.67%-121.3M
Other net revenue
2.65%-33.32M
36.67%-134.23M
19.58%-61.92M
-114.11%-51.36M
-1,698.46%-34.22M
-173.58%-211.97M
-224.95%-76.99M
-51.58%-23.99M
129.95%2.14M
-280.39%-77.48M
Fair value change income
----
-46.02%-8.36M
----
----
----
0.86%-5.72M
----
--355.83K
--1.92M
---5.77M
Invest income
68.58%-637.17K
18.98%8.92M
-249.03%-7.64M
-196.99%-4.44M
-376.29%-2.03M
-47.51%7.49M
-64.76%5.13M
-66.54%4.57M
-92.04%734.09K
-58.28%14.28M
-Including: Investment income associates
68.92%-637.17K
-675.34%-7.34M
-109.32%-7.12M
-119.98%-3.91M
-84.86%-2.05M
72.59%-946.55K
-93.13%-3.4M
-79.32%-1.78M
-3,866.24%-1.11M
-3,878.49%-3.45M
Asset deal income
-36.54%-11.42M
108.07%1.12M
-175.36%-796.21K
-662.00%-9.43M
-197.19%-8.36M
-3.10%-13.83M
--1.06M
--1.68M
5,060.88%8.61M
-68,633.64%-13.41M
Other revenue
-2.97%19.46M
19.07%71.82M
172.08%48.38M
82.93%32.72M
22.92%20.06M
13.09%60.32M
-54.07%17.78M
-16.48%17.89M
126.08%16.32M
67.08%53.33M
Operating profit
2.19%285.21M
-36.72%786.44M
5.38%786.5M
25.44%570.71M
37.86%279.09M
16.37%1.24B
-12.98%746.37M
-22.69%454.97M
-28.62%202.44M
16.34%1.07B
Add:Non operating Income
66.96%1.08M
-65.85%2.95M
-94.46%1.65M
-93.91%1.14M
-91.20%649.09K
-76.91%8.63M
46.76%29.83M
25.99%18.73M
-25.21%7.37M
-17.67%37.38M
Less:Non operating expense
-50.93%663.66K
430.46%86.83M
7.60%5.42M
-29.77%2.57M
170.78%1.35M
86.10%16.37M
-36.44%5.03M
-44.04%3.65M
-75.98%499.48K
36.76%8.8M
Total profit
2.60%285.63M
-43.11%702.56M
1.50%782.73M
21.11%569.28M
33.00%278.38M
12.63%1.23B
-11.38%771.17M
-21.24%470.06M
-28.17%209.31M
14.59%1.1B
Less:Income tax cost
11.58%39.32M
-35.97%142.15M
-5.65%90.93M
12.05%61.33M
2.92%35.24M
23.80%222M
-10.71%96.38M
-26.37%54.73M
8.90%34.24M
6.91%179.32M
Net profit
1.30%246.31M
-44.68%560.41M
2.52%691.8M
22.30%507.95M
38.88%243.15M
10.44%1.01B
-11.47%674.79M
-20.51%415.32M
-32.65%175.08M
16.22%917.21M
Net profit from continuing operation
1.30%246.31M
-44.68%560.41M
2.52%691.8M
22.30%507.95M
38.88%243.15M
10.44%1.01B
-11.47%674.79M
-20.51%415.32M
-32.65%175.08M
16.22%917.21M
Less:Minority Profit
19.26%4.39M
267.90%10.97M
328.53%5.88M
215.65%3.38M
185.54%3.68M
168.13%2.98M
-52.26%-2.57M
-116.28%-2.92M
-546.25%-4.31M
-451.12%-4.38M
Net profit of parent company owners
1.03%241.92M
-45.60%549.44M
1.26%685.92M
20.64%504.58M
33.49%239.46M
9.59%1.01B
-11.33%677.37M
-20.16%418.24M
-31.17%179.38M
16.66%921.58M
Earning per share
Basic earning per share
0.69%0.4059
-45.91%0.9207
1.01%1.1539
20.24%0.8489
32.64%0.4031
9.01%1.7022
-11.74%1.1424
-20.46%0.706
-31.18%0.3039
13.13%1.5615
Diluted earning per share
1.05%0.4059
-45.74%0.9206
1.13%1.153
20.34%0.8477
32.36%0.4017
9.05%1.6968
-11.62%1.1401
-20.36%0.7044
-31.02%0.3035
12.91%1.556
Other composite income
-289.75%-6.19M
104.25%83.04K
104.52%104.83K
97.65%-62.53K
25.31%3.26M
-1,543.16%-1.95M
-2,456.73%-2.32M
-1,119.37%-2.66M
482.79%2.6M
Other composite income of parent company owners
----
-289.75%-6.19M
104.25%83.04K
104.52%104.83K
97.65%-62.53K
25.31%3.26M
-1,543.16%-1.95M
-2,456.73%-2.32M
-1,119.37%-2.66M
482.79%2.6M
Total composite income
1.33%246.31M
-45.46%554.22M
2.83%691.89M
23.01%508.06M
40.99%243.08M
10.48%1.02B
-11.74%672.84M
-20.97%413.01M
-33.74%172.41M
16.66%919.81M
Total composite income of parent company owners
1.05%241.92M
-46.39%543.25M
1.57%686M
21.34%504.68M
35.47%239.4M
9.64%1.01B
-11.60%675.41M
-20.62%415.93M
-32.26%176.72M
17.09%924.19M
Total composite income of minority owners
19.26%4.39M
267.90%10.97M
328.53%5.88M
215.65%3.38M
185.54%3.68M
168.13%2.98M
-52.26%-2.57M
-116.28%-2.92M
-546.25%-4.31M
-451.12%-4.38M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 14.96%5.1B-0.29%17.38B6.55%12.81B8.92%8.68B11.02%4.44B19.50%17.43B14.55%12.03B18.85%7.97B16.53%4B15.26%14.59B
Operating revenue 14.96%5.1B-0.29%17.38B6.55%12.81B8.92%8.68B11.02%4.44B19.50%17.43B14.55%12.03B18.85%7.97B16.53%4B15.26%14.59B
Other operating revenue ----63.86%503.73M----84.92%293.12M-----1.54%307.42M-----1.40%158.52M----22.43%312.21M
Total operating cost 15.97%4.78B3.02%16.46B6.81%11.96B7.58%8.05B8.63%4.12B18.86%15.98B16.48%11.2B22.78%7.49B20.95%3.8B14.71%13.44B
Operating cost 20.44%3.55B2.85%11.65B10.03%8.57B10.77%5.76B11.42%2.95B23.12%11.32B19.89%7.79B27.00%5.2B22.54%2.65B13.22%9.2B
Operating tax surcharges -7.45%10.35M118.49%78.93M23.26%32.9M35.04%22.47M72.86%11.18M-8.33%36.13M-2.74%26.69M-2.03%16.64M-18.51%6.47M22.42%39.41M
Operating expense 5.83%1.09B4.00%4.23B-0.69%3B0.61%2.03B2.90%1.03B10.03%4.07B9.51%3.02B14.68%2.01B18.86%1B21.26%3.7B
Administration expense -5.39%106.31M-2.80%428.06M8.30%320.84M7.41%215.07M-1.00%112.38M10.35%440.38M6.47%296.25M8.37%200.23M8.61%113.52M-21.13%399.1M
Financial expense 9.00%18.53M-36.19%62.22M-45.45%38.87M-58.72%20.3M-32.79%17M-3.32%97.51M25.02%71.25M30.94%49.17M24.19%25.3M2,326.50%100.86M
-Interest expense (Financial expense) -2.60%35.7M-8.01%135.34M-9.54%94.62M-13.92%58.94M2.80%36.66M8.00%147.12M28.51%104.59M32.81%68.48M42.59%35.66M455.08%136.22M
-Interest Income (Financial expense) 10.16%-18.29M-45.26%-77.57M-60.96%-58.93M-92.78%-41.06M-79.29%-20.35M-36.06%-53.4M-34.98%-36.61M-36.15%-21.3M-83.25%-11.35M-62.41%-39.25M
Research and development 70.83%2.83M16.70%10.2M98.60%7.65M166.53%4.49M72.47%1.66M62.23%8.74M-0.38%3.85M-55.63%1.69M-49.88%962.08K542.08%5.39M
Credit Impairment Loss -28.66%-9.21M49.20%-42.78M26.02%-6.88M-35.65%-4.87M28.50%-7.16M-1,729.09%-84.22M-131.15%-9.3M-41.80%-3.59M-531.12%-10.01M-73.98%-4.6M
Asset Impairment Loss 14.20%-31.51M6.29%-164.94M-3.62%-94.97M-45.55%-65.33M-138.01%-36.73M-45.11%-176.01M-25.66%-91.66M7.21%-44.89M29.30%-15.43M-44.67%-121.3M
Other net revenue 2.65%-33.32M36.67%-134.23M19.58%-61.92M-114.11%-51.36M-1,698.46%-34.22M-173.58%-211.97M-224.95%-76.99M-51.58%-23.99M129.95%2.14M-280.39%-77.48M
Fair value change income -----46.02%-8.36M------------0.86%-5.72M------355.83K--1.92M---5.77M
Invest income 68.58%-637.17K18.98%8.92M-249.03%-7.64M-196.99%-4.44M-376.29%-2.03M-47.51%7.49M-64.76%5.13M-66.54%4.57M-92.04%734.09K-58.28%14.28M
-Including: Investment income associates 68.92%-637.17K-675.34%-7.34M-109.32%-7.12M-119.98%-3.91M-84.86%-2.05M72.59%-946.55K-93.13%-3.4M-79.32%-1.78M-3,866.24%-1.11M-3,878.49%-3.45M
Asset deal income -36.54%-11.42M108.07%1.12M-175.36%-796.21K-662.00%-9.43M-197.19%-8.36M-3.10%-13.83M--1.06M--1.68M5,060.88%8.61M-68,633.64%-13.41M
Other revenue -2.97%19.46M19.07%71.82M172.08%48.38M82.93%32.72M22.92%20.06M13.09%60.32M-54.07%17.78M-16.48%17.89M126.08%16.32M67.08%53.33M
Operating profit 2.19%285.21M-36.72%786.44M5.38%786.5M25.44%570.71M37.86%279.09M16.37%1.24B-12.98%746.37M-22.69%454.97M-28.62%202.44M16.34%1.07B
Add:Non operating Income 66.96%1.08M-65.85%2.95M-94.46%1.65M-93.91%1.14M-91.20%649.09K-76.91%8.63M46.76%29.83M25.99%18.73M-25.21%7.37M-17.67%37.38M
Less:Non operating expense -50.93%663.66K430.46%86.83M7.60%5.42M-29.77%2.57M170.78%1.35M86.10%16.37M-36.44%5.03M-44.04%3.65M-75.98%499.48K36.76%8.8M
Total profit 2.60%285.63M-43.11%702.56M1.50%782.73M21.11%569.28M33.00%278.38M12.63%1.23B-11.38%771.17M-21.24%470.06M-28.17%209.31M14.59%1.1B
Less:Income tax cost 11.58%39.32M-35.97%142.15M-5.65%90.93M12.05%61.33M2.92%35.24M23.80%222M-10.71%96.38M-26.37%54.73M8.90%34.24M6.91%179.32M
Net profit 1.30%246.31M-44.68%560.41M2.52%691.8M22.30%507.95M38.88%243.15M10.44%1.01B-11.47%674.79M-20.51%415.32M-32.65%175.08M16.22%917.21M
Net profit from continuing operation 1.30%246.31M-44.68%560.41M2.52%691.8M22.30%507.95M38.88%243.15M10.44%1.01B-11.47%674.79M-20.51%415.32M-32.65%175.08M16.22%917.21M
Less:Minority Profit 19.26%4.39M267.90%10.97M328.53%5.88M215.65%3.38M185.54%3.68M168.13%2.98M-52.26%-2.57M-116.28%-2.92M-546.25%-4.31M-451.12%-4.38M
Net profit of parent company owners 1.03%241.92M-45.60%549.44M1.26%685.92M20.64%504.58M33.49%239.46M9.59%1.01B-11.33%677.37M-20.16%418.24M-31.17%179.38M16.66%921.58M
Earning per share
Basic earning per share 0.69%0.4059-45.91%0.92071.01%1.153920.24%0.848932.64%0.40319.01%1.7022-11.74%1.1424-20.46%0.706-31.18%0.303913.13%1.5615
Diluted earning per share 1.05%0.4059-45.74%0.92061.13%1.15320.34%0.847732.36%0.40179.05%1.6968-11.62%1.1401-20.36%0.7044-31.02%0.303512.91%1.556
Other composite income -289.75%-6.19M104.25%83.04K104.52%104.83K97.65%-62.53K25.31%3.26M-1,543.16%-1.95M-2,456.73%-2.32M-1,119.37%-2.66M482.79%2.6M
Other composite income of parent company owners -----289.75%-6.19M104.25%83.04K104.52%104.83K97.65%-62.53K25.31%3.26M-1,543.16%-1.95M-2,456.73%-2.32M-1,119.37%-2.66M482.79%2.6M
Total composite income 1.33%246.31M-45.46%554.22M2.83%691.89M23.01%508.06M40.99%243.08M10.48%1.02B-11.74%672.84M-20.97%413.01M-33.74%172.41M16.66%919.81M
Total composite income of parent company owners 1.05%241.92M-46.39%543.25M1.57%686M21.34%504.68M35.47%239.4M9.64%1.01B-11.60%675.41M-20.62%415.93M-32.26%176.72M17.09%924.19M
Total composite income of minority owners 19.26%4.39M267.90%10.97M328.53%5.88M215.65%3.38M185.54%3.68M168.13%2.98M-52.26%-2.57M-116.28%-2.92M-546.25%-4.31M-451.12%-4.38M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg